Literature DB >> 3885998

Life expectancy of Swedish haemophiliacs, 1831-1980.

S A Larsson.   

Abstract

Life expectancy of Swedish haemophiliacs has been estimated for the period 1831-1980. The data were derived from 948 haemophiliacs of whom 580 survived throughout 1980. Applying standard demographic techniques, median life expectancy of patients with severe haemophilia was found to have increased fivefold, from a mere 11 years during the period 1831-1920 to 56.8 years during 1961-80. The corresponding estimates for patients with moderate haemophilia were 27.5 and 71.5 years, respectively. The limited data on patients with mild haemophilia did not indicate any significant improvements in mortality. From the beginning of this century to 1980 median life expectancy for Swedish males increased from 61.7 years to 75.6 years, an increase of 23%. Analysing the last 12 years of the study (1969-80), death rates for patients with severe haemophilia below the age of 45 were not much different from those of Swedish males in the population as a whole. The investigation implies that the mortality of haemophiliacs in Sweden is approaching that of the total male population.

Entities:  

Mesh:

Year:  1985        PMID: 3885998     DOI: 10.1111/j.1365-2141.1985.tb07353.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  24 in total

1.  Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysis.

Authors:  A H Bröcker-Vriends; F R Rosendaal; J C van Houwelingen; E Bakker; G J van Ommen; J J van de Kamp; E Briët
Journal:  J Med Genet       Date:  1991-10       Impact factor: 6.318

Review 2.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

3.  Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.

Authors:  D D Koeberl; C D Bottema; R P Ketterling; P J Bridge; D P Lillicrap; S S Sommer
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

Review 4.  The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review.

Authors:  Hector E Castro; María Fernanda Briceño; Claudia P Casas; Juan David Rueda
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-04       Impact factor: 0.900

5.  The use of blood components in the treatment of congenital coagulation disorders.

Authors:  I M Nilsson; S A Larsson; S E Bergentz
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

6.  Is major surgery in hemophiliac patients safe?

Authors:  W J Rudowski; R Scharf; J M Ziemski
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

7.  Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B.

Authors:  P M Green; S Saad; C M Lewis; F Giannelli
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

8.  The pattern of factor IX germ-line mutation in Asians is similar to that of Caucasians.

Authors:  C D Bottema; R P Ketterling; H S Yoon; S S Sommer
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

Review 9.  The contribution of DNA analysis to carrier detection and prenatal diagnosis of hemophilia A and B.

Authors:  A H Bröcker-Vriends; E Bakker; H H Kanhai; G J van Ommen; P H Reitsma; J J van de Kamp; E Briët
Journal:  Ann Hematol       Date:  1992-01       Impact factor: 3.673

10.  Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85.

Authors:  C Smit; F R Rosendaal; I Varekamp; A Bröcker-Vriends; H Van Dijck; T P Suurmeijer; E Briët
Journal:  BMJ       Date:  1989-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.